vs
Side-by-side financial comparison of MOVADO GROUP INC (MOV) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $186.1M, roughly 1.6× MOVADO GROUP INC). Bio-Techne runs the higher net margin — 12.8% vs 5.1%, a 7.7% gap on every dollar of revenue. On growth, MOVADO GROUP INC posted the faster year-over-year revenue change (1.9% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 2.9%).
Movado is a luxury American watch brand originally founded in 1881 in Switzerland. Movado means "movement" in Esperanto. The watches are known for their signature metallic dot at 12 o'clock and minimalist style; the company is best known for its Museum Watch.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
MOV vs TECH — Head-to-Head
Income Statement — Q3 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $186.1M | $295.9M |
| Net Profit | $9.6M | $38.0M |
| Gross Margin | 54.3% | 64.6% |
| Operating Margin | 6.3% | 18.4% |
| Net Margin | 5.1% | 12.8% |
| Revenue YoY | 1.9% | -6.4% |
| Net Profit YoY | 89.8% | 68.3% |
| EPS (diluted) | $0.42 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $186.1M | $295.9M | ||
| Q3 25 | $161.8M | — | ||
| Q2 25 | $131.8M | $317.0M | ||
| Q1 25 | $181.5M | $316.2M | ||
| Q4 24 | $180.5M | $297.0M | ||
| Q3 24 | $157.0M | $289.5M | ||
| Q2 24 | $134.4M | $306.1M | ||
| Q1 24 | $175.8M | $303.4M |
| Q4 25 | $9.6M | $38.0M | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $1.4M | $-17.7M | ||
| Q1 25 | $8.1M | $22.6M | ||
| Q4 24 | $4.8M | $34.9M | ||
| Q3 24 | $3.5M | $33.6M | ||
| Q2 24 | $2.0M | $40.6M | ||
| Q1 24 | $9.8M | $49.1M |
| Q4 25 | 54.3% | 64.6% | ||
| Q3 25 | 54.1% | — | ||
| Q2 25 | 54.1% | 62.7% | ||
| Q1 25 | 54.2% | 67.9% | ||
| Q4 24 | 53.5% | 65.3% | ||
| Q3 24 | 54.3% | 63.2% | ||
| Q2 24 | 54.3% | 66.4% | ||
| Q1 24 | 53.5% | 67.4% |
| Q4 25 | 6.3% | 18.4% | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 0.2% | -7.5% | ||
| Q1 25 | 5.1% | 12.2% | ||
| Q4 24 | 3.3% | 16.0% | ||
| Q3 24 | 1.7% | 13.8% | ||
| Q2 24 | 1.6% | 15.0% | ||
| Q1 24 | 6.1% | 22.1% |
| Q4 25 | 5.1% | 12.8% | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.1% | -5.6% | ||
| Q1 25 | 4.4% | 7.1% | ||
| Q4 24 | 2.7% | 11.7% | ||
| Q3 24 | 2.2% | 11.6% | ||
| Q2 24 | 1.5% | 13.3% | ||
| Q1 24 | 5.6% | 16.2% |
| Q4 25 | $0.42 | $0.24 | ||
| Q3 25 | $0.13 | — | ||
| Q2 25 | $0.06 | $-0.11 | ||
| Q1 25 | $0.36 | $0.14 | ||
| Q4 24 | $0.21 | $0.22 | ||
| Q3 24 | $0.15 | $0.21 | ||
| Q2 24 | $0.09 | $0.26 | ||
| Q1 24 | $0.44 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $183.9M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $497.5M | $2.0B |
| Total Assets | $751.9M | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.9M | $172.9M | ||
| Q3 25 | $180.5M | — | ||
| Q2 25 | $203.1M | $162.2M | ||
| Q1 25 | $208.5M | $140.7M | ||
| Q4 24 | $181.5M | $177.5M | ||
| Q3 24 | $198.3M | $187.5M | ||
| Q2 24 | $225.4M | $152.9M | ||
| Q1 24 | $262.1M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $497.5M | $2.0B | ||
| Q3 25 | $489.9M | — | ||
| Q2 25 | $493.2M | $1.9B | ||
| Q1 25 | $481.3M | $2.0B | ||
| Q4 24 | $491.3M | $2.1B | ||
| Q3 24 | $492.0M | $2.1B | ||
| Q2 24 | $489.6M | $2.1B | ||
| Q1 24 | $505.9M | $2.0B |
| Q4 25 | $751.9M | $2.5B | ||
| Q3 25 | $748.7M | — | ||
| Q2 25 | $747.2M | $2.6B | ||
| Q1 25 | $729.2M | $2.6B | ||
| Q4 24 | $747.2M | $2.7B | ||
| Q3 24 | $742.5M | $2.7B | ||
| Q2 24 | $736.0M | $2.7B | ||
| Q1 24 | $756.5M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | — |
| Free Cash FlowOCF − Capex | $11.6M | — |
| FCF MarginFCF / Revenue | 6.2% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | 1.28× | — |
| TTM Free Cash FlowTrailing 4 quarters | $35.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | — | ||
| Q3 25 | $-3.8M | — | ||
| Q2 25 | $-7.2M | $98.2M | ||
| Q1 25 | $39.1M | $41.1M | ||
| Q4 24 | $-4.7M | $84.3M | ||
| Q3 24 | $-17.8M | $63.9M | ||
| Q2 24 | $-18.1M | $75.5M | ||
| Q1 24 | $69.4M | $81.0M |
| Q4 25 | $11.6M | — | ||
| Q3 25 | $-5.1M | — | ||
| Q2 25 | $-8.7M | $93.3M | ||
| Q1 25 | $37.5M | $31.0M | ||
| Q4 24 | $-7.2M | $77.5M | ||
| Q3 24 | $-20.1M | $54.7M | ||
| Q2 24 | $-19.7M | $57.5M | ||
| Q1 24 | $67.8M | $64.5M |
| Q4 25 | 6.2% | — | ||
| Q3 25 | -3.1% | — | ||
| Q2 25 | -6.6% | 29.4% | ||
| Q1 25 | 20.7% | 9.8% | ||
| Q4 24 | -4.0% | 26.1% | ||
| Q3 24 | -12.8% | 18.9% | ||
| Q2 24 | -14.7% | 18.8% | ||
| Q1 24 | 38.6% | 21.3% |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.2% | 1.5% | ||
| Q1 25 | 0.9% | 3.2% | ||
| Q4 24 | 1.4% | 2.3% | ||
| Q3 24 | 1.5% | 3.2% | ||
| Q2 24 | 1.2% | 5.9% | ||
| Q1 24 | 0.9% | 5.4% |
| Q4 25 | 1.28× | — | ||
| Q3 25 | -1.27× | — | ||
| Q2 25 | -5.08× | — | ||
| Q1 25 | 4.86× | 1.82× | ||
| Q4 24 | -0.98× | 2.42× | ||
| Q3 24 | -5.14× | 1.90× | ||
| Q2 24 | -8.97× | 1.86× | ||
| Q1 24 | 7.06× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MOV
| Other | $81.4M | 44% |
| Owned Brands Category | $46.0M | 25% |
| Sales Channel Directly To Consumer | $35.3M | 19% |
| Company Stores | $23.4M | 13% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
